Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study.

Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study. J Acquir Immune Defic Syndr. 2022 12 15; 91(5):453-459.

View in: PubMed

subject areas

Anti-HIV Agents
Emtricitabine
Female
HIV Infections
Humans
Male
Medication Adherence
Motivational Interviewing
Pre-Exposure Prophylaxis
Text Messaging
Transgender Persons

authors with profiles

Katya C. Corado, MD